Funding · Commerce & Consumer Brands

Provilac raises $14 million in first institutional round

By Startup Enthusiast · 11 September 2026

What they do

Provilac produces fresh, high-protein milk and dairy products using ultrafiltration to increase protein content without adding powders

The company secured $14 million from Panthera Growth Partners, marking its first institutional funding round after a decade of bootstrapping

Provilac will use the capital to expand manufacturing, enter new markets like Bangalore, and innovate its fortified dairy portfolio

Provilac raised $14 million in its first institutional funding round.
The investment was led by Panthera Growth Partners as the sole investor.
The company plans to use the funds to increase its manufacturing capacity.
Provilac intends to enter new markets, specifically targeting Bangalore.
The startup will also focus on innovating its high-protein dairy product line.
Future product development includes dairy fortified with vitamins and micronutrients.

Provilac operated as a bootstrapped business for over a decade before this round.
The company aims to address India's protein gap, which is a significant unmet nutrition need.
Provilac serves over 50,000 households daily through its subscription-based delivery model.

Provilac specializes in high-protein milk and dairy products like curd and ghee.
Its flagship milk provides 25g of protein per 250ml serving, triple the amount of regular milk.
The company uses ultrafiltration to concentrate protein naturally without using protein powders.
Products are lactose-free and undergo third-party testing at NABL-accredited labs every three months.
The company maintains an integrated operation with control from the source to the customer's doorstep.
Distribution occurs primarily through the company's own app using a subscription model.
Provilac currently operates in Mumbai, Pune, Hyderabad, Delhi NCR, and Jaipur.
The company is expanding into Bangalore via platforms like FirstClub and Blinkit Gourmet.

Panthera Growth Partners (lead) — A Singapore-headquartered growth equity firm founded in 2021.